Anti Inflammatory Treatment of Hypertension

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT04740840

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Affiliated Hospital of North Sichuan Medical College (from the registry)
Registry
  • NCT NCT04740840
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04740840. Randomized; single masking; primary purpose treatment. Start 2010-05-01 (actual); primary completion 2012-04-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anti Inflammatory Treatment of Hypertension
Condition
Hypertension
Intervention (Drug)
Levamlodipine
Intervention (Drug)
Amlodipine
Lead sponsor
Affiliated Hospital of North Sichuan Medical College (class: other)
Collaborator
First Hospitals affiliated to the China PLA General Hospital (class: other government)

Record details

Record id
cardio:ct-nct04740840
Content hash
5943cbb6a16255b551adc674b7fd1bf1d05a49d925fd46deb41c4984ea3c0d8e